Medicare Enrolled
Dr. Patrick Bennett, M.D.
Urology Physician · Greenbrae, CA
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Bennett from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Bennett?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Bennett
Dr. Patrick Bennett is an urology physician in Greenbrae, CA, with 19 years of NPI registration. Based on federal Medicare data, Dr. Bennett performed 3,282 Medicare services across 2,616 unique beneficiaries.
Between the years covered by Open Payments, Dr. Bennett received a total of $5,553 from 47 pharmaceutical and/or device companies across 213 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in urology physician. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Bennett is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 19 years in practice
▲ Top 26% volume in CA
$5,553 industry payments
Medicare Practice Summary
Medicare Utilization ↗3,282
Medicare services
Top 26% in CA for urology physician
2,616
Unique beneficiaries
$87
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~173 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Urinalysis, manual A manual laboratory examination of a urine sample to check for various substances and cells. |
897 | $3 | $21 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
736 | $106 | $577 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
440 | $74 | $393 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
373 | $130 | $867 |
| Cystourethroscopy A diagnostic exam of the bladder and urethra using an endoscope to visually inspect the urinary tract. |
225 | $219 | $1,267 |
| Limited ultrasound of pelvis A focused ultrasound exam of the pelvic area to evaluate specific structures. This procedure provides images of the pelvis to assist in medical assessment. |
151 | $40 | $268 |
| Leuprolide acetate (for depot suspension), 7.5 mg | 88 | $126 | $1,399 |
| Simple change of bladder tube | 50 | $86 | $511 |
| New patient office visit (30-44 min) An initial office visit for a new patient lasting between 30 and 44 minutes. This code is used when the total time spent on the date of the encounter falls within this range. |
44 | $87 | $575 |
| Initial hospital admission, moderate complexity Initial hospital inpatient or observation care for a new patient involving moderate-level medical decision making, with at least 55 minutes total time on the date of the encounter. |
38 | $110 | $700 |
| Simple insertion of temporary bladder tube A procedure to place a temporary tube into the bladder. This allows for the drainage of urine from the bladder. |
35 | $59 | $471 |
| Transurethral prostate removal with electrocautery This procedure involves removing the prostate gland through the urethra using an endoscope and an electrocautery knife to control bleeding. |
32 | $610 | $3,793 |
| Insertion of temporary bladder tube | 26 | $38 | $357 |
| Bladder instillation of anti-cancer drug A procedure where an anti-cancer medication is introduced directly into the bladder. This method delivers the treatment locally to the bladder tissue. |
26 | $73 | $663 |
| Ureteral stent insertion via endoscope A flexible tube is inserted into the ureter using an endoscope to keep the passage open and allow urine to flow from the kidney to the bladder. |
25 | $120 | $3,308 |
| Subcutaneous or intramuscular chemotherapy injection This procedure involves administering anti-cancer hormonal medication through an injection into the tissue under the skin or into a muscle. |
20 | $32 | $178 |
| Bladder aspiration with tube insertion Removal of fluid from the bladder using a needle or tube, followed by the placement of a catheter through the skin into the bladder. |
14 | $60 | $2,468 |
| Ureteral stone crushing with stent insertion An endoscope is used to break up a stone in the ureter, followed by the placement of a stent to keep the ureter open. |
14 | $331 | $2,140 |
| Groin hernia repair, age 5 or older Surgical repair of a hernia in the groin area for patients aged 5 years or older. |
12 | $445 | $2,634 |
| Endoscopic removal of bladder or urethra growth, 2.0-5.0 cm This procedure uses an endoscope to destroy or remove a growth from the bladder or urethra that measures between 2.0 and 5.0 centimeters. |
12 | $210 | $1,491 |
| Office visit, established patient (10-19 min) An office visit for an existing patient lasting 10 to 19 minutes. The visit involves medical evaluation and management of the patient's condition. |
12 | $45 | $241 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
12 | $151 | $773 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
1.2% high complexity
5.2% medium
93.6% routine
Industry Payment Transparency
Open Payments through 2024 ↗$5,553
Total received (2018-2024)
Avg $793/year across 7 years
Top 31% in CA for urology physician
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
47
Companies
213
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$5,385 (97.0%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$168 (3.0%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$1,581
2023
$1,532
2022
$735
2021
$433
2020
$258
2019
$445
2018
$568
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Sumitomo Pharma America, Inc.
$217
ABBVIE INC.
$195
Axonics, Inc.
$168
Telix Pharmaceuticals
$149
Ferring Pharmaceuticals Inc.
$144
Laborie Medical Technologies Corp.
$121
Ambu Inc.
$79
Becton, Dickinson and Company
$76
PFIZER INC.
$60
ConvaTec Inc.
$56
PROCEPT BioRobotics Corporation
$54
Astellas Pharma US Inc
$53
Boston Scientific Corporation
$33
IMMUNITYBIO, INC.
$31
UROGEN PHARMA, INC.
$31
C. R. Bard, Inc. & Subsidiaries
$30
Myriad Genetic Laboratories, Inc.
$24
ACCORD HEALTHCARE, INC.
$24
COLOPLAST CORP
$21
Dendreon Pharmaceuticals LLC
$16
Top 3 companies account for 36.6% of 2024 payments
All-time payments by company (2018-2024) ›
Sumitomo Pharma America, Inc.
$706
Astellas Pharma US Inc
$534
Boston Scientific Corporation
$423
Rochester Medical Corporation
$317
AbbVie Inc.
$286
ABBVIE INC.
$254
Blue Earth Diagnostics Limited
$195
Axonics, Inc.
$185
AbbVie, Inc.
$185
C. R. Bard, Inc. & Subsidiaries
$181
Janssen Biotech, Inc.
$154
Telix Pharmaceuticals
$149
Ferring Pharmaceuticals Inc.
$144
Laborie Medical Technologies Corp.
$121
Ambu Inc.
$115
PFIZER INC.
$113
Allergan Inc.
$110
UroGen Pharma, Inc.
$109
EDAP TECHNOMED INC
$100
Myriad Genetic Laboratories, Inc.
$97
Dendreon Pharmaceuticals LLC
$88
Becton, Dickinson and Company
$76
BOSTON SCIENTIFIC CORPORATION
$72
Tolmar, Inc.
$59
ConvaTec Inc.
$56
PROCEPT BioRobotics Corporation
$54
NeoTract Inc.
$53
Allergan, Inc.
$50
UROGEN PHARMA, INC.
$45
Teleflex LLC
$42
C. R. BARD, INC. & SUBSIDIARIES
$39
COLOPLAST CORP
$38
Antares Pharma, Inc.
$38
Boehringer Ingelheim Pharmaceuticals, Inc.
$36
ROCHESTER MEDICAL CORPORATION
$36
Sagent Pharmaceuticals, Inc.
$35
AngioDynamics, Inc.
$34
IMMUNITYBIO, INC.
$31
Palette Life Sciences, Inc.
$28
Ethicon US, LLC
$26
Amgen Inc.
$25
ACCORD HEALTHCARE, INC.
$24
Myovant Sciences Inc.
$23
Abbott Laboratories
$21
Supernus Pharmaceuticals, Inc.
$17
Olympus America Inc.
$15
SANOFI PASTEUR INC.
$14
Top 3 companies account for 30.0% of all-time payments
Associated products mentioned in payments ›
ADACEL · ADSTILADRIN · AMS · ANKTIVA · AQUABEAM SYSTEM · Androgel · Axonics · Axonics r-SNM System · Axumin · BOTOX · BOTOX THERAPEUTIC · Bard Urinary Drainage Bag · CAMCEVI · ELIGARD · ERLEADA · EVENITY · Enseal X1 · GEMTESA · GENERAL BPH · GENERAL KIDNEY STONE DISEASE · GENTLECATH · GENTLECATH GLIDE · General - Kidney Stone Disease · Glydo · ILLUCCIX · JARDIANCE · JELMYTO · LITHOVUE · LITHOVUE EMPOWER · LUPRON DEPOT · Lupron · Lupron Depot · MAGIC3 · MYRBETRIQ · Myrbetriq · NANOKNIFE · NOCDURNA · NanoKnife · ORGOVYX · Optilume BPH Drug Coated Balloon Catheter · POSLUMA · PROLARIS · PROVENGE · Porges Coloplast · Proclaim IPG · Prolaris · REZUM · Rezum Generator · SPACEOAR VUE · SpaceOAR VUE System - 10mL · Titan · UROLIFT · UroLift · UroLift System · VESICARE · XTANDI · XYOSTED · ZYTIGA · iTIND System
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (97%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Geographic Context
Urology physicians within 10 mi
95
Per 100K population
36.7
County median income
$142,785
Nearest hospital
MARINHEALTH MEDICAL CENTER
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Bennett is a clinical cardiology specialist, with above-average Medicare volume (top 26% in CA), with low-engagement industry engagement, with 19 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Bennett experienced with urinalysis, manual?
Based on Medicare claims data, Dr. Bennett performed 897 urinalysis, manual services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Bennett receive payments from pharmaceutical companies?
Yes. Dr. Bennett received a total of $5,553 from 47 companies across 213 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Bennett's costs compare to other urology physicians in Greenbrae?
Dr. Bennett's average Medicare payment per service is $87. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Bennett) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Urology Physicians in Greenbrae
Browse urology physicians in Greenbrae ranked by procedure volume and transparency data.
Highest volume
Top Urology Physicians in CA
Urology physicians ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Urology Physicians in CA
Which CA urology physicians receive the most from drug and device companies.
By company
Sumitomo Pharma America, Inc. Payments to Doctors
See all physicians who received payments from Sumitomo Pharma America, Inc.
By company
Astellas Pharma US Inc Payments to Doctors
See all physicians who received payments from Astellas Pharma US Inc.
By company
Boston Scientific Corporation Payments to Doctors
See all physicians who received payments from Boston Scientific Corporation.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology